Federal Register / Vol. 63, No. 110 /Tuesday, June 9, 1998 / Notices 31515

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

Epidemiology and Prevention Conflicts.

Date: June 10, 1998.

Time: 1:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Crystal City Courtyard Marriott,

2899 Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Kesinee Nimit, Md, Health

Scientist Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

5600 Fishers Lane, Room 10–22, Rockville,

MD 20857.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: June 2, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–15287 Filed 6–8–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of person privacy.

Name of Committee: Behavioral and

Neurosciences Special Emphasis Panel

Cellular & Molecular Development

Neuroscience 7.

Date: June 9–10, 1998.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Ave, Bethesda, MD 20814.

Contact Person: Stephen Gobel, DDS,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4112,

MSC 7816, BETHESDA, MD 20892, (301)

435–1783.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: June 9, 1998.

Time: 1:30 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Daniel B. Berch, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 5204, MSC 7848,

BETHESDA, MD 20892, (301) 435–1256.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel ZRG2 NTN (01).

Date: June 9, 1998.

Time: 2:30 p.m. to 5:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Room 3016,

Bethesda, MD 20892.

Contact Person: Sooja K. Kim, PHD, RD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 6158,

MSC 7892, BETHESDA, MD 20892, (301)

435–1780.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Behavioral and

Neurosciences Special Emphasis Panel.

Date: June 10–11, 1998.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Governer’s House Holiday Inn, 17th

St & Rhode Island Ave, NW, Washington, DC

20036.

Contact Person: Carl D. Banner, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5212,

MSC 7850, BETHESDA, MD 20892, (302)

435–1251.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: June 11, 1998.

Time: 8:30 AM to 3:30 PM.

Agenda: To review and evaluate and grant

applications.

Place: Holiday Inn, 5520 Wisconsin Ave,

Chevy Chase, MD 20815.

Contact Person: Betty Hayden, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4206,

MSC 7812, BETHESDA, MD 20892, (301)

435–1223.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: June 15, 1998.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott, 5151 Pooks Hill

Rd, Bethesda, MD 20814.

Contact Person: Nabeeh Mourad, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4212,

MSC 7812, BETHESDA, MD 20892.

This notice is being published less than 15

days prior the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Clinical Sciences

Special Emphasis Panel.

Date: June 16–17, 1998.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Geogretown Inn, 1310 Wisconsin

Ave., N.W., Washington, DC 2007.

Contact Person: Jo Pelham, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4106, MSC 7814,

BETHESDA, MD 20892, (301) 435–1786.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Chemistry and

Related Sciences Special Emphasis Panel.

Date: June 25–26, 1998.

Time: 2:00 PM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: The Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Marjam G. Behar, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4178,

MSC 7806, BETHESDA, MD 20892, (301)

435–1180.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: June 29–30, 1998.

Time: 8:00 AM to 11:30 AM.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Nabeeh Mourad, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of
31516 Federal Register / Vol. 63, No. 110 /Tuesday, June 9, 1998 / Notices

Health, 6701 Rockledge Drive, Room 4212,

MSC 7812, BETHESDA, MD 20892.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel ZRG2–GMA–02–(01M).

Date: June 30, 1998.

Time: 1:00 PM to 2:00 PM.

Agenda: To review and evaluate grant

applications.

Place: 6701 Rockledge Drive, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Mushtaq A. Khan, DVM,

PHD, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 4124, MSC 7818, BETHESDA, MD

20892, (301) 435–1778, khanm@drg.nih.gov.

Name of Committee: Microbiological and

Immunological Sciences Special Emphasis

Panel ZRG–5 AARR–03.

Date: July 1–2, 1998.

Time: 8:30 AM to 4:00 PM.

Agenda: to review and evaluate grant

applications.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Mohindar Poonian, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5110,

MSC 7852, BETHESDA, MD 20892, (301)

435–1168.

Name of Committee: Clinical Sciences

Special Emphasis Panel.

Date: July 7–8, 1998.

Time: 2:00 p.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 5520 Wisconsin Ave,

Chevy Chase, MD 20815.

Contact Person: Shirley Hilden, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4218,

MSC 7814, BETHESDA, MD 20892, (301)

435–1198.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel ZRG2–GMA2–(02B).

Date: July 8, 1998.

Time: 8:30 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: ANA Hotel, 2401 M Street, NW.,

Washington, DC 20037.

Contact Person: Mushtaq A. Khan, DVM,

PHD, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 4124, MSC 7818, BETHESDA, MD

20892, (301) 435–1778, khanm@drg.nih.gov.

Name of Committee: Clinical Sciences

Special Emphasis Panel ZRG4–UROL–02.

Date: July 8, 1998.

Time: 10:00 a.m. to 12:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Shirley Hilden, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4218,

MSC 7814, BETHESDA, MD 20892, (301)

435–1198.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: July 8, 1998.

Time: 1:00 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn National Airport, 1489

Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Everett Sinnett, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4120,

MSC 7818, BETHESDA, MD 20892, (301)

435–1016, evlsinnett@nih.gov.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: July 9–10, 1998.

Time: 2:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Ave, Washington, DC 20007.

Contact Person: Syed M. Quadri, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4144,

MSC 7804, BETHESDA, MD 20892, (301)

435–1211.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: July 19–20, 1998.

Time: 1:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Ave, Washington, DC 20007.

Contact Person: Syed M. Quadri, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4144,

MSC 7804, BETHESDA, MD 20892, (301)

435–1211.

Name of Committee: Biological and

Physiological Sciences Special Emphasis

Panel.

Date: July 28, 1998.

Time: 8:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Reston Hotel, Reston, VA.

Contact Person: Ramesh K. Nayak, PHD,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 5146, MSC 7840, BETHESDA, MD

20892, (301) 435–1026.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: June 2, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–15288 Filed 6–8–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

In compliance with Section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995 concerning

opportunity for public comment on

proposed collections of information, the

Substance Abuse and Mental Health

Services Administration will publish

periodic summaries of proposed

projects. To request more information

on the proposed projects or to obtain a

copy of the information collection

plans, call the SAMHSA Reports

Clearance Officer on (301) 443–7978.

Comments are invited on: (a) Whether

the proposed collections of information

are necessary for the proper

performance of the functions of the

agency, including whether the

information shall have practical utility;

(b) the accuracy of the agency’s estimate

of the burden of the proposed collection

of information; (c) ways to enhance the

quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Proposed Project

Testing of Substance Abuse

Prevention and Treatment and Mental

Health Services Communication

Messages—NEW—As the Federal

agency responsible for developing and

disseminating authoritative knowledge

about substance abuse prevention,

addition treatment, and mental health

services and for mobilizing consumer

support and increasing public

understanding to overcome the stigma

attached to addiction and mental

illness, the Substance Abuse and Mental

Health Services Administration

(SAMHSA) is responsible for

development and dissemination of a

wide range of education and

information materials for both the

general public and the professional

communities. This submission will

provide for formative and qualitative

evaluation activities to: (1) Assess

audience knowledge, attitudes, behavior

and other characteristics for the

planning and development of messages,

communication strategies and public

information programs; and (2) test these

messages, strategies and program